Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial
Publication
, Conference
Prasad, VK; Papanicolaou, GA; Maron, GM; Vainorius, E; Brundage, TM; Chittick, G; Nichols, G; Grimley, MS
Published in: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2017
Duke Scholars
Published In
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
EISSN
1523-6536
ISSN
1083-8791
Publication Date
2017
Volume
23
Issue
3
Start / End Page
S52 / S53
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Prasad, V. K., Papanicolaou, G. A., Maron, G. M., Vainorius, E., Brundage, T. M., Chittick, G., … Grimley, M. S. (2017). Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial. In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (Vol. 23, pp. S52–S53).
Prasad, Vinod K., Genovefa A. Papanicolaou, Gabriela M. Maron, Enrikas Vainorius, Thomas M. Brundage, Greg Chittick, Garrett Nichols, and Michael S. Grimley. “Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial.” In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23:S52–53, 2017.
Prasad VK, Papanicolaou GA, Maron GM, Vainorius E, Brundage TM, Chittick G, et al. Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2017. p. S52–3.
Prasad, Vinod K., et al. “Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial.” BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 23, no. 3, 2017, pp. S52–53.
Prasad VK, Papanicolaou GA, Maron GM, Vainorius E, Brundage TM, Chittick G, Nichols G, Grimley MS. Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2017. p. S52–S53.
Published In
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
EISSN
1523-6536
ISSN
1083-8791
Publication Date
2017
Volume
23
Issue
3
Start / End Page
S52 / S53
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences